How many patents does
Ptc Therapeutics have?
patents
878
families
93
granted
213
applications
665
US
201
EP
118
WO
65
JP
49
CN
45
KR
24
RoW
376
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Ptc Therapeutics
Top ten assignees appearing on patents
2009 - 2018
| ptc therapeutics | 726 |
| roche | 86 |
| schering corporation | 17 |
| pct therapeutics | 9 |
| pitisi terap'jutiks | 2 |
| ptc therapuetics | 1 |
| ptc therpeutics | 1 |
| ptc thrapeutics | 1 |
| amgen | 1 |
| therapeutics | 1 |
2009
| ptc therapeutics | 46 |
| pct therapeutics | 1 |
2018
| ptc therapeutics | 72 |
| roche | 9 |
| pct therapeutics | 1 |
Ptc Therapeutics
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| 1,2,4-oxadiazole benzoic acid compositions and their use in bioassays | 66 | 2003 |
| crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid | 53 | 2006 |
| compounds for treating spinal muscular atrophy | 51 | 2012 |
| methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression t… 🛈 | 48 | 2006 |
| carboline derivatives useful in the inhibition of angiogenesis | 35 | 2004 |
| compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression ther… 🛈 | 34 | 2005 |
| processes for the preparation of 1,2,4-oxadiazole benzoic acids | 31 | 2006 |
| substituted reverse pyrimidine bmi-1 inhibitors | 29 | 2012 |
| compounds for nonsense suppression, and methods for their use | 28 | 2004 |
| methods for treating cancer and non-neoplastic conditions | 23 | 2009 |